Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
Don't Guess Your Pet's Condition, Treat It with ImpriMed
Startup to Follow
Learn More →
In the News
Meet The Inventors: Sungwon Lim of ImpriMed On How To Go From Idea To Store Shelf
Authority Magazine
Learn More →
Scientific Publications
Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model
Veterinary Sciences
Learn More →
Presentations
ImpriMed: Experiences from the eyes of an oncologist in clinical practice
Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model
Veterinary Cancer Society Annual Conference 2021
Learn More →
Press Releases
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
EIN Presswire
Learn More →
In the News
Interview with ImpriMed CEO & Co-Founder Sungwon Lim
IdeaMensch
Learn More →
Video/Podcast Interviews
Interview with Dr. Sungwon Lim, CEO of ImpriMed
Innovating with Scott Amyx
Learn More →
Video/Podcast Interviews
Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed
Tech Founder Show by Insivia
Learn More →
Press Releases
ImpriMed Initiates Feline Lymphoma Drug Response Prediction Study
EIN Presswire
Learn More →
In the News
This Test Might Make All The Difference When Fighting Lymphoma
Canine Cancer Alliance
Learn More →
Press Releases
ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma
GlobeNewswire
Learn More →
Press Releases
ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
GlobeNewswire
Learn More →
In the News
ImpriMed: Fighting Cancer — From Dogs To Humans
Startup Thread
Learn More →
Press Releases
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
PR Underground
Learn More →
Video/Podcast Interviews
Which Drugs Can Kill Your Dog's Cancer Cells? - ImpriMed's Sungwon Lim | Canine Cancer Rebel
Canine Cancer Alliance
Learn More →
Presentations
ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients
Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model
Veterinary Cancer Society Annual Conference 2020
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
